Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
John Zajecka
JCP
Article
Antidepressant Dosing and Switching Guidelines: Focus on Nefazodone
JCP
Original Research
Changes in Adverse Events Reported by Patients During 6 Months of Fluoxetine Therapy
JCP
Article
Clinical Management of Antidepressant Discontinuation
JCP
Original Research
Discontinuation Symptoms After Treatment With Serotonin Reuptake Inhibitors: A Literature Review
JCP
Original Research
Efficacy and Safety of Mirtazapine in Major Depressive Disorder Patients After SSRI Treatment Failure: An Open-Label Trial
JCP
Article
Importance of Establishing the Diagnosis of Persistent Anxiety
JCP
Article
Possible Biological Mechanisms of the Serotonin Reuptake Inhibitor Discontinuation Syndrome
JCP
Academic Highlights
Residual Symptoms in Major Depressive Disorder: Prevalence, Effects, and Management
JCP
Article
Serotonin Reuptake Inhibitor Discontinuation Syndrome: A Hypothetical Definition
JCP
Original Research
Sexual Function and Satisfaction in the Treatment of Chronic Major Depression With Nefazodone, Psychotherapy, and Their Combination
JCP
Article
Six-Year Perspectives on the Safety and Tolerability of Nefazodone
PCC
Article
Strategies for the Treatment of Antidepressant-Related Sexual Dysfunction
JCP
Original Research
Symptomatic and Syndromal Anxiety in Chronic Forms of Major Depression: Effect of Nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, and Their Combination
JCP
Article
Strategies for the Treatment of Antidepressant-Related Sexual Dysfunction
PCC
Academic Highlights
Residual Symptoms in Major Depressive Disorder: Prevalence, Effects, and Management
JCP
Case Report
Safety and Tolerability of Concomitant Intranasal Esketamine and MAOI Treatment
Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in some patients.